Wednesday, April 19, 2023

< + > Abbott Is Bouncing Back From Baby Formula Problems And Lost Covid Test Sales

Abbott Laboratories is rebounding from last year’s manufacturing shutdown of its U.S. baby formula plant thanks to strong medical device sales taking the place of lost revenue of COVID-19 tests.

No comments:

Post a Comment

< + > Glytec Secures $36 Million Growth Investment to Accelerate AI-Powered Diabetes Technology Platform Innovation

Glytec , the leading provider of an AI-powered technology platform for diabetes and related conditions, today announced it has closed a $36 ...